INTRODUCTION

59
Newcastle Disease virus (NDV) is one of the most important infectious agents in 60
Veterinary medicine and the causative agent of Newcastle Disease (ND) that affects 61 commercial poultry causing important economical losses (2). The virus belongs to the 62 family Paramyxoviridae, subfamily Paramyxovirinae, in the genus Avulavirus (14) and 63 encompasses a diverse group of single-stranded, negative-sense, nonsegmented RNA 64 viruses. Due to variation in virulence and hosts susceptibility, the symptoms of NDV 65 infection in domestic species (chicken, turkey, goose, duck and pigeon) range from 66 unapparent to severe, including respiratory, enteric and nervous system disease leading 67 to high mortality rates (2). 68
Antigenic and genetic diversity are recognized within the NDV isolates (1) . 69 Different genotypes of NDV circulate throughout the world, albeit they are all members 70 of a unique avian Paramyxovirus group 1 (APMV-1) serotype. Since 1926 and based on 71 nucleotide sequence, nine class I and ten distinct lineages of class II NDV (I to IX, and 72 XI) have been identified (6, 11, 17) . Molecular characterization is of paramount 73 importance for the epidemiology studies required in the development and adaptation of 74 control strategies (10). Genotypes V, VI, and VII virulent viruses are the predominant 75 genotypes circulating worldwide (16, 17) and from these, genotype VII is particularly 76 important given that it has been associated with many of the most recent outbreaks in Asia, 77 Africa and the Middle East (10, 11, 12, 28, 29) . 78
Vaccination of commercially reared birds is the best way to reduce losses 79 resulting from NDV infection (2, 21). NDV vaccine strains from genotypes I and II are 80 used to control detrimental effects of sub-clinical forms of the disease and severe 81 clinical disease during outbreaks (2, 23, 27 vaccination protocol recommended to producers in Venezuela. A vaccine/challenge trial 141 using three groups of commercial broilers was designed and implemented as follows: At 142 day 1 two (2) groups were vaccinated by spray with live VG/GA strain followed by 143 subcutaneous (SC) application of 0.1 ml inactivated in oil adjuvant Ulster strain (G01 144 and G02). The third group remained as unvaccinated control (G03). The G01 and G03 145 were transported to a controlled environment (experimental farm) with water and feed 146 provided at libitum. The G02 birds were wing banded and translated to a 20.000 bird 147 commercial chicken house. G01 and G02 were vaccinated at 7 and 17 days by drinking 148 water against NDV and IBDV following manufacturer's instructions. At 1, 14, 21 and 149 28 days of age 10 birds per group were bled and assessed for ND and IBDV response to 150 vaccination using enzyme-linked immunosorbent assay (ELISA), with FlockCheck hours. Tissues were then processed and embedded in paraffin, using routine histological 162 techniques. The relative bursa /body weight ratio was obtained using the formula 163
[relative bursa weight = (bursa weight/body weight) × 1000]. The extent of bursal 164 histological damage was graded on a scale from 1 to 4 as previously described (24). 165
Briefly, 1 = normal to 10% follicular atrophy; 2 = focal, mild scattered cell depletion up 166 to 10-30% follicular atrophy; 3 = multifocal follicular atrophy 30-70%; 4 = diffuse 167 atrophy of > 70% of the follicles or any evidence of acute necrosis. (1, 7, 10,16, 17, 18, 25,) (Table 2) . 234
The differences in humoral immune response and protection observed are 235 noteworthy (Figure 2) , additional results show that at challenge age (28 days) the 236 bursa/body weight ratio that was 2.03 vs 0.9 in the experimental set and the field 237 
